Advertisement
News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Biogen slides as MS drug is linked to inflammation

October 22, 2014 12:26 pm | by The Associated Press | News | Comments

Shares of Biogen Idec slumped 8 percent Wednesday despite a strong quarter after the pharmaceutical said a patient who took its newest multiple sclerosis drug suffered a brain inflammation and later died. The company confirmed there was a case of progressive multifocal leukoencephalopathy, or...

Dozens released Ebola-free from Sierra Leone site

October 22, 2014 11:27 am | by Kabba Kargbo - Associated Press - Associated Press | News | Comments

FREETOWN, Sierra Leone (AP) — Dozens of Ebola survivors were discharged from a treatment center near Sierra leone's capital on Wednesday and told they were virus-free. The third group released from the Hastings Treatment center, which included 45 patients, were also issued with health...

Imaging and Analysis with Flying Colors: Part One

October 22, 2014 8:30 am | by Mark Clymer, Director of Marketing, Datacolor Inc. | Articles | Comments

Researchers are facing increasing demands from colleagues, peers and publishers for process documentation including adequate controls, and for extensive documentation of experimental parameters. Without such consideration, there would be little chance to repeat, or even validate, findings.

TOPICS:
Advertisement

J&J to spend up to $200M on Ebola vaccine program

October 22, 2014 8:26 am | by The Associated Press | News | Comments

Johnson & Johnson will start safety testing in early January on a vaccine combination that could protect people from a strain of the deadly Ebola virus. The health care products maker says it has committed up to $200 million to speed up and expand production of a vaccine program being...

German firm wins appeal in Spain thalidomide case

October 22, 2014 6:27 am | by The Associated Press | News | Comments

A Spanish court has upheld an appeal by a German pharmaceutical company, ditching a previous ruling that ordered the company to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide. Madrid*s provincial court announced the ruling Wednesday, saying the statute of...

Red Cross Official: 6 Months to Contain Ebola

October 22, 2014 3:26 am | by The Associated Press | News | Comments

A top Red Cross official says he is confident the Ebola epidemic can be contained within four to six months. The Ebola outbreak has killed more than 4,500 people since it emerged 10 months ago, with Liberia, Guinea and Sierra Leone the worst-affected countries.

TOPICS:

Ebola airport checks expand; nurses get training

October 22, 2014 3:26 am | by Connie Cass - Associated Press - Associated Press | News | Comments

The federal government is closing a gap in Ebola screening at airports while states from New York to Texas to California work to get hospitals and nurses ready in case another patient turns up somewhere in the U.S. with the deadly disease. Under the rule going into effect Wednesday, air travelers...

Ebola victim's sister says hospital denied request

October 21, 2014 11:26 pm | by Emily Schmall - Associated Press - Associated Press | News | Comments

The family of the first Ebola victim to die in the United States says the hospital that cared for him has refused for weeks to release lab results showing the effects of an experimental drug treatment, fanning their suspicions that the facility mishandled the case. They believe that information...

Advertisement

Third Point urges Amgen to consider breakup

October 21, 2014 8:25 pm | by The Associated Press | News | Comments

A hedge fund run by a famed investor said Tuesday it has taken a large stake in Amgen and now wants the biotech drugmaker to consider splitting up into two. In a letter to investors, Third Point, a hedge fund run by Daniel Loeb, said it has recently increased its stake by an unspecified amount,...

Study finds drugs still in recalled supplements

October 21, 2014 6:25 pm | by Lindsey Tanner - AP Medical Writer - Associated Press | News | Comments

Dietary supplements containing potentially dangerous prescription drug ingredients may still be for sale even years after safety recalls, a study found. In supplements bought online, researchers detected hidden steroids, similar ingredients to Viagra and Prozac and a weight loss drug linked with...

Syringe Drive for Precise Liquid Handling

October 21, 2014 1:20 pm | Product Releases | Comments

The Hamilton Precision Syringe Drive 6 (PSD/60 is a compact, full-height pump for precision dispensing of small to large volumes. 

Seeing is Believing: Reproducible Proteomic Studies

October 21, 2014 1:03 pm | by Anton Posch, Senior Scientist, Bio-Rad Laboratories | Articles | Comments

For scientists, the field of proteomics has always been a double-edged sword. On one hand, technologies such as 2-dimensional gel electrophoresis (2-DE) capture a vastly improved picture of protein expression in action. But when others try to reproduce the experiment? The findings can suddenly appear blurry.

TOPICS:

Orbitrap-based Mass Spectrometer

October 21, 2014 12:47 pm | Product Releases | Comments

The Thermo Scientific Q Exactive Focus LC-MS/MS is designed to make the qualitative and quantitative power of Orbitrap-based instruments available to customers who use quadrupole time-of-flight (Q-TOF) mass spectrometry or other technologies.

TOPICS:

Cancer Drug Resistance Has an ‘Off Switch’

October 21, 2014 11:29 am | Videos | Comments

Scientists have uncovered details about how cancer is able to become drug resistant over time, a phenomenon that occurs because cancer cells within the same tumor aren’t identical.                     

TOPICS:

See-through Sensors Open New Window into the Brain

October 21, 2014 11:18 am | News | Comments

Developing invisible implantable medical sensor arrays, a team of engineers has overcome a major technological hurdle in researchers’ efforts to understand the brain.                         

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading